· Compound K, a metabolite of ginsenosides, induces cardiac protection mediated nitric oxide via Akt/PI3K pathway
· Akt/PI

· Subchronic toxicity studies with ginsenoside compound K delivered to dogs via intravenous administration
· 개에게 정맥내투여를 통하

· Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes

· Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating
adenosine-5′monophosphate kinase: A study i

· Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3
inflammasome activation

· Hypoglycemic effect of protopanaxadiol-type ginsenosides and compound K on Type 2 Diabetes mice
induced by High-Fat Diet

· Compound K protects MIN6N8 pancreatic β‐cells against palmitate‐induced apoptosis through modulating SAPK/JNK activation

· Anti-diabetic effects of compound K versus metformin versus compound K-metformin combination therapy in diabetic db/db mice

· Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice
· db/db Mice에서 인슐린 분비 조절 기능에 관여하는